查看購物車
  • English
2025-2029年全球製藥業機器學習展望
市場調查報告書
商品編碼
1915695

2025-2029年全球製藥業機器學習展望

Global Machine Learning In Pharmaceutical Industry Market 2025-2029
出版日期: | 出版商: TechNavio | 英文 323 Pages | 訂單完成後即時交付

價格
簡介目錄

全球製藥業機器學習市場預計將以 37.1% 的複合年成長率成長，在 2024 年至 2029 年的預測期內達到 102.128 億美元。本報告對全球製藥業機器學習市場進行了全面分析，包括市場規模和預測、趨勢、成長要素和挑戰，以及對約 25 家公司的供應商分析。

本報告提供對當前市場格局、最新趨勢和促進因素以及整體市場環境的最新分析。市場成長的促進因素包括數據量和複雜性的增加、對提高效率和降低成本的需求，以及個人化和精準醫療的發展。

本研究採用客觀的方法，結合一手和二手訊息，包括來自主要行業相關人員的意見。報告包含對主要企業的分析、全面的市場規模數據、區域細分分析以及供應商格局。報告提供歷史數據和預測數據。

市場覆蓋範圍
基準年 2025
目標期 2029
預測期 2025-2029
成長勢頭 加速度
同比 34.6%
複合年成長率 37.1%
增量 102.128億美元

研究指出，生成式人工智慧在新藥研發領域的興起是未來幾年推動全球製藥業機器學習市場成長的主要因素之一。此外，聯邦學習在資料隱私保護方面的日益普及，以及人工智慧與數位生物標記和穿戴式技術的日益融合，預計也將為市場帶來巨大的需求。

目錄

第1章執行摘要

第2章 Technavio 分析

  • 價格、生命週期、顧客購買籃、採用率和購買標準分析
  • 投入與差異化因素的重要性
  • 混淆來源
  • 促進因素和挑戰的影響

第3章 市場情勢

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析

第4章 市場規模

  • 市場定義
  • 市場區隔分析
  • 2024年市場規模
  • 2024-2029年市場展望

第5章 市場規模表現

  • 2019-2023年全球製藥業機器學習市場
  • 應用細分市場分析 2019-2023
  • 2019-2023年技術細分市場分析
  • 2019-2023年部署細分市場分析
  • 2019-2023年區域細分市場分析
  • 2019-2023年國家細分市場分析

第6章五力分析

  • 五力分析概述
  • 買方的議價能力
  • 供應商的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭威脅
  • 市場狀況

第7章 按應用程式進行市場區隔

  • 比較：透過應用
  • 藥物發現與設計
  • 臨床試驗最佳化
  • 疾病診斷和生物標記鑑定
  • 生產製造和品管
  • 其他
  • 按應用分類的市場機會

8. 按技術分類的市場細分

  • 比較：按技術
  • 監督式學習
  • 深度學習
  • 無監督學習
  • 強化學習
  • 其他
  • 按技術分類的市場機遇

9. 依部署方式進行市場區隔

  • 比較：依部署方式
  • 基於雲端的
  • 混合
  • 本地部署
  • 按部署方式分類的市場機會

第10章 客戶情況

第11章 區域情勢

  • 區域細分
  • 區域比較
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 荷蘭
    • 西班牙
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 以色列
    • 土耳其
  • 各區域的市場機遇

第12章：促進因素、挑戰與機遇

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場機遇

第13章 競爭格局

  • 概述
  • 競爭格局
  • 令人困惑的局面
  • 產業風險

第14章 競爭分析

  • 公司簡介
  • 企業排名指數
  • 公司市場定位
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Bristol Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • IQVIA Holdings Inc.
  • Johnson and Johnson Services
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Ltd.

第15章附錄

簡介目錄
Product Code: IRTNTR81090

The global machine learning in pharmaceutical industry market is forecasted to grow by USD 10212.8 mn during 2024-2029, accelerating at a CAGR of 37.1% during the forecast period. The report on the global machine learning in pharmaceutical industry market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing data volume and complexity, quest for enhanced efficiency and reduced costs, personalized medicine and precision therapies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 202534.6%
CAGR37.1%
Incremental Value$10212.8 mn

Technavio's global machine learning in pharmaceutical industry market is segmented as below:

By Application

  • Drug discovery and design
  • Clinical trial optimization
  • Disease diagnosis and biomarker identification
  • Manufacturing and quality control
  • Others

By Technology

  • Supervised learning
  • Deep learning
  • Unsupervised learning
  • Reinforcement learning
  • Others

By Deployment

  • Cloud-based
  • Hybrid
  • On premises

Geography

  • North America
    • US
    • Canada
    • Mexico
  • APAC
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • The Netherlands
    • Spain
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • UAE
    • South Africa
    • Turkey
  • Rest of World (ROW)

This study identifies the rise of generative AI for de novo drug design as one of the prime reasons driving the global machine learning in pharmaceutical industry market growth during the next few years. Also, increasing adoption of federated learning for data privacy and integration of AI with digital biomarkers and wearable technology will lead to sizable demand in the market.

The report on the global machine learning in pharmaceutical industry market covers the following areas:

  • Global machine learning in pharmaceutical industry market sizing
  • Global machine learning in pharmaceutical industry market forecast
  • Global machine learning in pharmaceutical industry market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global machine learning in pharmaceutical industry market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Atomwise Inc., Bayer AG, Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, ICON plc, Insilico Medicine, IQVIA Holdings Inc., Johnson and Johnson Services, Merck and Co. Inc., Novartis AG, Pfizer Inc., Recursion Pharmaceuticals Inc., Sanofi SA, Takeda Pharmaceutical Ltd.. Also, the global machine learning in pharmaceutical industry market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by Technology
    • Executive Summary - Chart on Market Segmentation by Deployment
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
  • 2.3 Factors of disruption
  • 2.4 Impact of drivers and challenges

3 Market Landscape

  • 3.1 Market ecosystem
  • 3.2 Market characteristics
  • 3.3 Value chain analysis

4 Market Sizing

  • 4.1 Market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029

5 Historic Market Size

  • 5.1 Global Machine Learning In Pharmaceutical Industry Market 2019 - 2023
    • Historic Market Size - Data Table on Global Machine Learning In Pharmaceutical Industry Market 2019 - 2023 ($ million)
  • 5.2 Application segment analysis 2019 - 2023
    • Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • 5.3 Technology segment analysis 2019 - 2023
    • Historic Market Size - Technology Segment 2019 - 2023 ($ million)
  • 5.4 Deployment segment analysis 2019 - 2023
    • Historic Market Size - Deployment Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Five Forces Analysis

  • 6.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 6.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 6.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 6.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 6.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 6.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 6.7 Market condition

7 Market Segmentation by Application

  • 7.1 Market segments
  • 7.2 Comparison by Application
  • 7.3 Drug discovery and design - Market size and forecast 2024-2029
  • 7.4 Clinical trial optimization - Market size and forecast 2024-2029
  • 7.5 Disease diagnosis and biomarker identification - Market size and forecast 2024-2029
  • 7.6 Manufacturing and quality control - Market size and forecast 2024-2029
  • 7.7 Others - Market size and forecast 2024-2029
  • 7.8 Market opportunity by Application
    • Market opportunity by Application ($ million)

8 Market Segmentation by Technology

  • 8.1 Market segments
  • 8.2 Comparison by Technology
  • 8.3 Supervised learning - Market size and forecast 2024-2029
  • 8.4 Deep learning - Market size and forecast 2024-2029
  • 8.5 Unsupervised learning - Market size and forecast 2024-2029
  • 8.6 Reinforcement learning - Market size and forecast 2024-2029
  • 8.7 Others - Market size and forecast 2024-2029
  • 8.8 Market opportunity by Technology
    • Market opportunity by Technology ($ million)

9 Market Segmentation by Deployment

  • 9.1 Market segments
  • 9.2 Comparison by Deployment
  • 9.3 Cloud-based - Market size and forecast 2024-2029
  • 9.4 Hybrid - Market size and forecast 2024-2029
  • 9.5 On premises - Market size and forecast 2024-2029
  • 9.6 Market opportunity by Deployment
    • Market opportunity by Deployment ($ million)

10 Customer Landscape

  • 10.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

  • 11.1 Geographic segmentation
  • 11.2 Geographic comparison
  • 11.3 North America - Market size and forecast 2024-2029
    • 11.3.1 US - Market size and forecast 2024-2029
    • 11.3.2 Canada - Market size and forecast 2024-2029
    • 11.3.3 Mexico - Market size and forecast 2024-2029
  • 11.4 APAC - Market size and forecast 2024-2029
    • 11.4.1 China - Market size and forecast 2024-2029
    • 11.4.2 India - Market size and forecast 2024-2029
    • 11.4.3 Japan - Market size and forecast 2024-2029
    • 11.4.4 South Korea - Market size and forecast 2024-2029
    • 11.4.5 Australia - Market size and forecast 2024-2029
    • 11.4.6 Indonesia - Market size and forecast 2024-2029
  • 11.5 Europe - Market size and forecast 2024-2029
    • 11.5.1 Germany - Market size and forecast 2024-2029
    • 11.5.2 UK - Market size and forecast 2024-2029
    • 11.5.3 France - Market size and forecast 2024-2029
    • 11.5.4 Italy - Market size and forecast 2024-2029
    • 11.5.5 The Netherlands - Market size and forecast 2024-2029
    • 11.5.6 Spain - Market size and forecast 2024-2029
  • 11.6 South America - Market size and forecast 2024-2029
    • 11.6.1 Brazil - Market size and forecast 2024-2029
    • 11.6.2 Argentina - Market size and forecast 2024-2029
    • 11.6.3 Colombia - Market size and forecast 2024-2029
  • 11.7 Middle East and Africa - Market size and forecast 2024-2029
    • 11.7.1 Saudi Arabia - Market size and forecast 2024-2029
    • 11.7.2 UAE - Market size and forecast 2024-2029
    • 11.7.3 South Africa - Market size and forecast 2024-2029
    • 11.7.4 Israel - Market size and forecast 2024-2029
    • 11.7.5 Turkey - Market size and forecast 2024-2029
  • 11.8 Market opportunity by geography
    • Market opportunity by geography ($ million)
    • Data Tables on Market opportunity by geography ($ million)

12 Drivers, Challenges, and Opportunity

  • 12.1 Market drivers
    • Increasing data volume and complexity
    • Quest for enhanced efficiency and reduced costs
    • Personalized medicine and precision therapies
  • 12.2 Market challenges
    • Data silos and interoperability issues
    • Regulatory and ethical considerations
    • Talent gap and skill shortages
  • 12.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 12.4 Market opportunities
    • Rise of generative AI for de novo drug design
    • Increasing adoption of federated learning for data privacy
    • Integration of AI with digital biomarkers and wearable technology

13 Competitive Landscape

  • 13.1 Overview
  • 13.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 13.3 Landscape disruption
    • Overview on factors of disruption
  • 13.4 Industry risks
    • Impact of key risks on business

14 Competitive Analysis

  • 14.1 Companies profiled
    • Companies covered
  • 14.2 Company ranking index
    • Company ranking index
  • 14.3 Market positioning of companies
    • Matrix on companies position and classification
  • 14.4 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
    • SWOT
  • 14.5 Amgen Inc.
    • Amgen Inc. - Overview
    • Amgen Inc. - Product / Service
    • Amgen Inc. - Key news
    • Amgen Inc. - Key offerings
    • SWOT
  • 14.6 AstraZeneca Plc
    • AstraZeneca Plc - Overview
    • AstraZeneca Plc - Product / Service
    • AstraZeneca Plc - Key news
    • AstraZeneca Plc - Key offerings
    • SWOT
  • 14.7 Bayer AG
    • Bayer AG - Overview
    • Bayer AG - Business segments
    • Bayer AG - Key news
    • Bayer AG - Key offerings
    • Bayer AG - Segment focus
    • SWOT
  • 14.8 Bristol Myers Squibb Co.
    • Bristol Myers Squibb Co. - Overview
    • Bristol Myers Squibb Co. - Product / Service
    • Bristol Myers Squibb Co. - Key news
    • Bristol Myers Squibb Co. - Key offerings
    • SWOT
  • 14.9 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key offerings
    • SWOT
  • 14.10 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 14.11 GlaxoSmithKline Plc
    • GlaxoSmithKline Plc - Overview
    • GlaxoSmithKline Plc - Business segments
    • GlaxoSmithKline Plc - Key news
    • GlaxoSmithKline Plc - Key offerings
    • GlaxoSmithKline Plc - Segment focus
    • SWOT
  • 14.12 IQVIA Holdings Inc.
    • IQVIA Holdings Inc. - Overview
    • IQVIA Holdings Inc. - Business segments
    • IQVIA Holdings Inc. - Key offerings
    • IQVIA Holdings Inc. - Segment focus
    • SWOT
  • 14.13 Johnson and Johnson Services
    • Johnson and Johnson Services - Overview
    • Johnson and Johnson Services - Business segments
    • Johnson and Johnson Services - Key news
    • Johnson and Johnson Services - Key offerings
    • Johnson and Johnson Services - Segment focus
    • SWOT
  • 14.14 Merck and Co. Inc.
    • Merck and Co. Inc. - Overview
    • Merck and Co. Inc. - Business segments
    • Merck and Co. Inc. - Key news
    • Merck and Co. Inc. - Key offerings
    • Merck and Co. Inc. - Segment focus
    • SWOT
  • 14.15 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
    • SWOT
  • 14.16 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 14.17 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
    • SWOT
  • 14.18 Takeda Pharmaceutical Ltd.
    • Takeda Pharmaceutical Ltd. - Overview
    • Takeda Pharmaceutical Ltd. - Product / Service
    • Takeda Pharmaceutical Ltd. - Key news
    • Takeda Pharmaceutical Ltd. - Key offerings
    • SWOT

15 Appendix

  • 15.1 Scope of the report
    • Market definition
    • Objectives
    • Notes and caveats
  • 15.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 15.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 15.4 Research methodology
    • Research methodology
  • 15.5 Data procurement
    • Information sources
  • 15.6 Data validation
    • Data validation
  • 15.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 15.8 Data synthesis
    • Data synthesis
  • 15.9 360 degree market analysis
    • 360 degree market analysis
  • 15.10 List of abbreviations
    • List of abbreviations